Medical Oncologist
CION Cancer Clinics
Patient assistance and drug access programmes for liver cancer | CION Cancer Clinics
Some liver cancer drugs in India come with patient assistance programmes, and generics, biosimilars and government schemes can lower the bill further. Whether any of these helps you depends on the drug chosen, your income and the paperwork. This page explains the routes, how to apply before the first dose, and who a programme cannot help. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can a patient assistance programme help pay for liver cancer drugs in India?
- What kinds of drug access help exist for liver cancer?
- How do you apply for a drug assistance programme?
- What do the words on an assistance form mean?
- Who will an assistance programme not help?
- What this page cannot tell you
- Common questions about drug access programmes
The short answer
Can a patient assistance programme help pay for liver cancer drugs in India?
Sometimes, yes. Several companies that make immunotherapy and targeted drugs for liver cancer run patient assistance programmes in India, and some of them reduce the number of doses a family has to buy. Whether one applies to you depends on the drug your oncologist has chosen, your income, your paperwork and the rules the company is using that year.
What these programmes usually are
Most are run by the drug company itself, often through an outside agency that checks the forms. A common pattern is a "buy some, receive some" arrangement, where after a set number of purchased doses the company supplies further doses without charge. Others are means-tested and look at family income. A few cover a whole course for families who qualify.
Why this page sits with the treatment decisions
For hepatocellular carcinoma (HCC, the commonest primary liver cancer), the first-choice drugs today are often immunotherapy combinations such as atezolizumab plus bevacizumab. They are expensive, and cost can quietly decide which drug a family starts. Knowing what help exists before the first dose lets the choice be made on the medicine, with the money question answered openly.
This page is about primary liver cancer. If cancer has spread to the liver from the bowel or elsewhere, the drugs and the programmes are different.Where help comes from
What kinds of drug access help exist for liver cancer?
There are four broad routes. Many families end up using two of them together.
Company assistance programmes
Run by the maker of a branded immunotherapy or targeted drug. The terms differ for every drug and change from year to year. Your oncology team or the pharmacy usually knows whether one is running.
Usually asks for
- A prescription and diagnosis summary
- Proof of identity and address
- Income proof for means-tested schemes
- Bills for doses already bought
Generic and biosimilar versions
Some targeted tablets are sold in India by several makers at lower prices. Copies of antibody drugs, called biosimilars, exist for some medicines. Read what to know about generics and biosimilars before switching.
Government schemes
Aarogyasri, Ayushman Bharat PM-JAY, CGHS, ECHS and ESI may cover some cancer drugs under set packages. What is included changes, and newer immunotherapy may not be on the list. Check at the time of treatment.
Relief funds and charities
The Chief Minister's Relief Fund, the Prime Minister's fund and some trusts give one-off grants. They are slow and never certain, so they work best alongside another route.
No route is promised in advance. Apply to more than one where the rules allow.Not sure whether this applies to you?
Ask an oncologistApplying, step by step
How do you apply for a drug assistance programme?
Ask before the first dose
Many programmes only count doses bought after you enrol. Ask your oncologist and the pharmacy, at the planning visit, whether a programme exists for the drug being proposed.
Get the medical papers ready
You will need the prescription, the biopsy or scan report that confirms the diagnosis, and a short letter from the treating oncologist. CION's team can help prepare these.
Collect identity and income proof
Aadhaar, a ration card or income certificate, and sometimes bank statements. Keep photocopies, and scanned copies on your phone.
Keep every bill
Original invoices with batch numbers are often what proves you bought the qualifying doses. A lost bill can mean a lost dose.
Follow up in writing
Ask for an application number and the expected timeline. Do not delay treatment while you wait unless your oncologist says a short wait is safe.
On the forms
What do the words on an assistance form mean?
- Patient assistance programme (PAP)
- A company scheme that lowers what the patient pays for one branded drug, under conditions the company sets.
- Means-tested
- Help that depends on family income or assets. You will be asked to prove what the household earns.
- Biosimilar
- A close copy of an antibody drug, approved after testing that it behaves like the original. It is not an identical chemical copy.
- Named-patient or compassionate access
- A route to a drug not yet sold in India, usually through import on a doctor's request. It is slow, rare and depends on approval.
- Implementing agency
- An outside firm the drug company uses to check forms and release doses. Families often deal with them directly.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Did you know
Assistance programmes usually cover only the drug itself. Scans, blood tests, the endoscopy needed before bevacizumab, day-care charges and medicines for side effects are billed separately, so ask for a written, itemised estimate of everything else too.
Who this does not suit
Who will an assistance programme not help?
A programme only helps if the drug itself is right for you. Help with cost cannot make an unsuitable drug safe. Your liver function, your fitness and the stage of the cancer come first.
When the drug is not the right plan
Systemic drugs are used mainly when the cancer cannot be removed, ablated or controlled by treatment through the blood vessels. If your liver is badly scarred, with Child-Pugh C function (the most damaged grade), the team may advise supportive care over any drug, and a programme does not change that. People who have had a liver transplant are usually not offered immunotherapy at all.
When the drug is not covered
Not every drug has a programme, and programmes close without warning. Drugs only available through import or trials sit outside most of them. Families already covered in full by an insurer or a scheme may not qualify. If cost is the real barrier, say so to your oncologist. There is often more than one reasonable drug, and the monthly cost of each option is a fair part of that conversation.
Being straight with you
What this page cannot tell you
It cannot tell you whether a programme is open today for a particular drug, or whether your family will qualify. Companies change their terms, and we do not publish any company's rules here because they would soon be out of date. Your oncology team and the pharmacy hear about changes first.
It cannot promise money from any scheme
Government schemes and relief funds decide case by case. The details, package lists and limits change and must be checked at the time. Pages on Aarogyasri cover and relief fund applications explain how those work in more detail.
It is not financial or legal advice
For insurance disputes or scheme refusals, ask the scheme helpdesk, your insurer's grievance cell, or a hospital social worker. CION's team helps with scheme paperwork and can point you to the right office.
Questions we are asked
Common questions about drug access programmes
Is there a patient assistance programme for atezolizumab in India?
The maker of atezolizumab has run assistance schemes in India, but the terms and eligibility change. Ask your oncologist or the dispensing pharmacy before the first dose, because doses bought before enrolment often do not count. Bevacizumab, given with it, may have a separate arrangement or a biosimilar option.
Do I need to be poor to qualify?
Not always. Some programmes are open to anyone prescribed the drug and simply reduce the number of doses bought. Others are means-tested and ask for income proof. The form will tell you which kind it is, and your oncology team can help you read it.
Can I use a programme and Aarogyasri together?
Sometimes, but the rules of each must allow it, and a drug supplied under a scheme package usually cannot also be claimed through a company. Ask the scheme desk and the programme agency before you start, and keep every bill and approval letter in one folder.
Are sorafenib and lenvatinib cheaper than immunotherapy?
Generic versions of these tablets are often cheaper than branded immunotherapy. Whether a tablet suits you depends on your liver and the cancer, not only the price. The lenvatinib insurance page covers what schemes and insurers may pay for.
Is a biosimilar as good as the original?
An approved biosimilar has been tested to behave like the original drug. It is not an identical copy, and switching midway should be agreed with your oncologist. For many families it is a sensible way to lower cost without changing the plan itself.
What if a drug is not available in India?
Some newer liver cancer drugs reach India late or only through trials or import. Named-patient import is slow, rare and needs approval. Ask whether an available drug would serve you nearly as well, and whether a suitable clinical trial is open, before chasing an import.
Should I delay treatment while my form is processed?
Usually not. Advanced liver cancer can change quickly, and liver function can fall while you wait. Ask your oncologist whether a short wait is safe. If it is not, start treatment and keep the bills, since some programmes still count later purchases.
Can CION help me apply?
Yes. CION's team helps families with scheme paperwork and with the medical documents programmes ask for, such as the diagnosis summary and the oncologist's letter. Call the helpline and say which drug has been proposed, and someone will explain what help may exist.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Managing Cancer Costs and Medical Information
- American Cancer Society — Immunotherapy for Liver Cancer
- American Cancer Society — Targeted Drug Therapy for Liver Cancer
- National Cancer Institute — Liver Cancer Treatment
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
The monthly cost of each systemic optionWhat each drug choice tends to cost before any helpGeneric and biosimilar versionsThe other main way families lower the drug billChief Minister's Relief Fund and PM Relief FundHow one-off grants work and what they ask forQuestions to ask before starting systemic treatmentThe full list to take to the planning visit
Talk to us
Worried the drug you need is out of reach?
Tell us which drug has been proposed and we will explain what help may exist and what paperwork it needs. One helpline serves every CION centre.